Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Fatigue in HD patients may be related to endotoxemia and inflammation through IL-6.
|
31541903 |
2020 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Plasma cytokine concentrations increased profoundly during endotoxaemia (control group: tumor necrosis factor alpha [TNF-α] from 14 [9-16] pg ml<sup>-1</sup> at baseline to 480 [284-709] pg ml<sup>-1</sup> at 1.5 h after LPS; interleukin-6 [IL-6] from 4 [4-4] pg ml<sup>-1</sup> at baseline to 659 [505-1018] pg ml<sup>-1</sup> at 2 h after LPS).
|
31084985 |
2019 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
The α7 nAChR partial agonist GTS-21 reduces secretion of pro-inflammatory cytokines including interleukin-6 (IL6) and tumor-necrosis factor (TNF) in models of endotoxemia and sepsis, and its anti-inflammatory effects are widely ascribed to α7 nAChR activation.
|
30947238 |
2019 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
LAH also significantly reduced the concentration of tumour cell necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in both serum and colon and decreased the level of lipopolysaccharides (LPS) in serum and feces, leading to reduced systematic inflammation and metabolic endotoxemia.
|
31099356 |
2019 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
20TT in the heat increased I-FABP and elevated inflammatory cytokines (IL-6 and TNF-α) compared to pre-exercise values but did not result in endotoxemia.
|
31565753 |
2019 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
In vivo, levels of IL-1β, IL-6, and TNFα in the lungs and liver were markedly reduced during endotoxemia in IL-37Tg mice but not observed in IL-37D20ATg mice.
|
30792349 |
2019 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
It alleviated tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in activated macrophages by downregulating the NF-κB activity, and it reduced the mortality rate in LPS induced endotoxemia mice.
|
30297806 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
At postoperative day 7, the sepsis-positive group continued to demonstrate an increase in intestinal permeability, endotoxemia and elastase; a significant difference was observed between the two groups (P = 0.02), whereas there was no significant difference in IL-1, IL-6, and CRP levels.
|
28803860 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Finally, treating neonatal mice with IFNβ 2 h after endotoxemia stimulated pulmonary STAT1 signaling and STAT1 dependent gene expression.
|
30319651 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
In addition, it resulted in the reduction of endotoxemia (through lipopolysaccharides (LPSs)) and pro-inflammatory cytokine (tumor necrosis factor alpha (TNF-α), interleukin 6 (IL-6), and interleukin 1β (IL-1β)) levels, with the increased expression of tight-junction associated proteins (claudin-1, occludin, and zonula occludens-1).
|
30065236 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, leptin pre-treatment decreased the oxidative stress burst in blood and blunted the increased pro-inflammatory cytokines TNF-α, IL-1β, and IL-6 observed during endotoxemia.
|
30618812 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, endotoxemia (LBP) was negatively correlated with serum testosterone but positively correlated with IL-6.
|
29183872 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Furthermore, therapeutic studies in a systemic endotoxemia model demonstrated that mSPAM treatment reduced TNF-α and IL-6 inflammatory cytokines in serum, in turn circumventing organ damage done by the inflammatory macrophages.
|
30247915 |
2018 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
We aimed to assess in obese youths the relationships between interleukin-6 (IL-6), fat meal-induced endotoxemia and glucose homeostasis.
|
28216642 |
2017 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Opioid users also had higher endotoxemia and IL-6 but not IL-17.
|
27868217 |
2017 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin.
|
24681566 |
2014 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
Treatment with both AGE and RGE in an in vivo experiment of LPS-induced endotoxemia significantly reduced the level of TNF-α and interleukin-6 in serum and completely protected against LPS-induced lethal shock in C57BL/6 mice.
|
25238199 |
2014 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
RGD |
Application of thrombelastography in liver injury induced by endotoxin in rat.
|
22227956 |
2012 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
300 min after the proinflammatory insult, plasma concentrations of IL-1β and IL-6 in the plasma remain considerably lower after CLI compared to endotoxemia.
|
21296198 |
2011 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
RGD |
In vivo anticoagulant effect of ethyl pyruvate in endotoxemic rats.
|
21396682 |
2011 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
Changes in blood glucose and glucose tolerance, plasma IL-6, triglycerides, and body temperature were characteristic of endotoxemia.
|
21914473 |
2011 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
RGD |
Protective effects of melatonin against the damages of neuroendocrine-immune induced by lipopolysaccharide in diabetic rats.
|
19449282 |
2009 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
Reciprocal regulation of IL-6 and IL-10 balance by HGF via recruitment of heme oxygenase-1 in macrophages for attenuation of liver injury in a mouse model of endotoxemia.
|
19578789 |
2009 |
Endotoxemia
|
0.300 |
AlteredExpression
|
phenotype |
BEFREE |
Quantification of IL-6 mRNA expression in circulating leukocytes is unlikely a suitable marker for monitoring of endotoxemia.
|
15721840 |
2005 |
Endotoxemia
|
0.300 |
Biomarker
|
phenotype |
BEFREE |
The IL-6 G(-174)C promoter polymorphism does not significantly influence basal concentrations of IL-6 or peak IL-6 in human endotoxemia.
|
14709647 |
2004 |